Reproducibility of radioactive iodine uptake (RAIU) measurements

Matthieu Pelletier-Galarneau, Patrick Martineau, Ran Klein, Matthew Henderson, Lionel S. Zuckier

Research output: Contribution to journalArticle

Abstract

Background: Measurement of radioactive iodine uptake (RAIU) is an important aspect of the assessment and treatment of patients with hyperthyroidism. Its uncertainty affects how much of a true change in RAIU can be detected as well as appropriateness of the therapy dosage upon which it is based. In this study, a method of estimating the reproducibility and least significant change (LSC) values for RAIU measurements, and the implications of the values observed are discussed, with emphasis on application to quality assurance initiatives. Methods: We prospectively studied 36 consecutive patients referred for RAIU measurements. Twenty-four hours after oral administration of 370 kBq of 131I-NaI in capsule form, RAIU measurements were obtained in duplicate using a thyroid probe uptake system. Assessment of reproducibility was performed using root-mean-square standard deviation. Results: Average difference between duplicated RAIU measurements in our study cohort was -0.1 ± 1.6% and ranged from -4.8% to 3.1%. Reproducibility of probe-based RAIU measurement was calculated to be 1.1% and 95% LSC was 3.2%. Conclusion: In our clinic, probe-based RAIU is a reproducible and relatively precise measurement. Using the method we have outlined, each institution can perform reproducibility assessment and compute the LSC of RAIU measurements based on its own staff, iodine isotope, equipment, protocols, and patient population. These values are useful in the assessment of serial change in RAIU, and as more experience is accumulated, can serve as benchmarks to be used in quality assurance initiatives.

Original languageEnglish (US)
Pages (from-to)239-242
Number of pages4
JournalJournal of Applied Clinical Medical Physics
Volume19
Issue number1
DOIs
StatePublished - Jan 2018
Externally publishedYes

Fingerprint

Iodine
iodine
assurance
Quality assurance
probes
Iodine Isotopes
iodine isotopes
Benchmarking
Hyperthyroidism
capsules
Uncertainty
Capsules
Oral Administration
standard deviation
therapy
Thyroid Gland
Isotopes
Cohort Studies
estimating
Equipment and Supplies

Keywords

  • Hyperthyroidism
  • Radioiodine therapy
  • Radioiodine thyroid uptake
  • Reproducibility

ASJC Scopus subject areas

  • Radiation
  • Instrumentation
  • Radiology Nuclear Medicine and imaging

Cite this

Reproducibility of radioactive iodine uptake (RAIU) measurements. / Pelletier-Galarneau, Matthieu; Martineau, Patrick; Klein, Ran; Henderson, Matthew; Zuckier, Lionel S.

In: Journal of Applied Clinical Medical Physics, Vol. 19, No. 1, 01.2018, p. 239-242.

Research output: Contribution to journalArticle

Pelletier-Galarneau, Matthieu ; Martineau, Patrick ; Klein, Ran ; Henderson, Matthew ; Zuckier, Lionel S. / Reproducibility of radioactive iodine uptake (RAIU) measurements. In: Journal of Applied Clinical Medical Physics. 2018 ; Vol. 19, No. 1. pp. 239-242.
@article{42ec6ac9dc894618980fcc5fd31abcfb,
title = "Reproducibility of radioactive iodine uptake (RAIU) measurements",
abstract = "Background: Measurement of radioactive iodine uptake (RAIU) is an important aspect of the assessment and treatment of patients with hyperthyroidism. Its uncertainty affects how much of a true change in RAIU can be detected as well as appropriateness of the therapy dosage upon which it is based. In this study, a method of estimating the reproducibility and least significant change (LSC) values for RAIU measurements, and the implications of the values observed are discussed, with emphasis on application to quality assurance initiatives. Methods: We prospectively studied 36 consecutive patients referred for RAIU measurements. Twenty-four hours after oral administration of 370 kBq of 131I-NaI in capsule form, RAIU measurements were obtained in duplicate using a thyroid probe uptake system. Assessment of reproducibility was performed using root-mean-square standard deviation. Results: Average difference between duplicated RAIU measurements in our study cohort was -0.1 ± 1.6{\%} and ranged from -4.8{\%} to 3.1{\%}. Reproducibility of probe-based RAIU measurement was calculated to be 1.1{\%} and 95{\%} LSC was 3.2{\%}. Conclusion: In our clinic, probe-based RAIU is a reproducible and relatively precise measurement. Using the method we have outlined, each institution can perform reproducibility assessment and compute the LSC of RAIU measurements based on its own staff, iodine isotope, equipment, protocols, and patient population. These values are useful in the assessment of serial change in RAIU, and as more experience is accumulated, can serve as benchmarks to be used in quality assurance initiatives.",
keywords = "Hyperthyroidism, Radioiodine therapy, Radioiodine thyroid uptake, Reproducibility",
author = "Matthieu Pelletier-Galarneau and Patrick Martineau and Ran Klein and Matthew Henderson and Zuckier, {Lionel S.}",
year = "2018",
month = "1",
doi = "10.1002/acm2.12217",
language = "English (US)",
volume = "19",
pages = "239--242",
journal = "Journal of Applied Clinical Medical Physics",
issn = "1526-9914",
publisher = "American Institute of Physics Publising LLC",
number = "1",

}

TY - JOUR

T1 - Reproducibility of radioactive iodine uptake (RAIU) measurements

AU - Pelletier-Galarneau, Matthieu

AU - Martineau, Patrick

AU - Klein, Ran

AU - Henderson, Matthew

AU - Zuckier, Lionel S.

PY - 2018/1

Y1 - 2018/1

N2 - Background: Measurement of radioactive iodine uptake (RAIU) is an important aspect of the assessment and treatment of patients with hyperthyroidism. Its uncertainty affects how much of a true change in RAIU can be detected as well as appropriateness of the therapy dosage upon which it is based. In this study, a method of estimating the reproducibility and least significant change (LSC) values for RAIU measurements, and the implications of the values observed are discussed, with emphasis on application to quality assurance initiatives. Methods: We prospectively studied 36 consecutive patients referred for RAIU measurements. Twenty-four hours after oral administration of 370 kBq of 131I-NaI in capsule form, RAIU measurements were obtained in duplicate using a thyroid probe uptake system. Assessment of reproducibility was performed using root-mean-square standard deviation. Results: Average difference between duplicated RAIU measurements in our study cohort was -0.1 ± 1.6% and ranged from -4.8% to 3.1%. Reproducibility of probe-based RAIU measurement was calculated to be 1.1% and 95% LSC was 3.2%. Conclusion: In our clinic, probe-based RAIU is a reproducible and relatively precise measurement. Using the method we have outlined, each institution can perform reproducibility assessment and compute the LSC of RAIU measurements based on its own staff, iodine isotope, equipment, protocols, and patient population. These values are useful in the assessment of serial change in RAIU, and as more experience is accumulated, can serve as benchmarks to be used in quality assurance initiatives.

AB - Background: Measurement of radioactive iodine uptake (RAIU) is an important aspect of the assessment and treatment of patients with hyperthyroidism. Its uncertainty affects how much of a true change in RAIU can be detected as well as appropriateness of the therapy dosage upon which it is based. In this study, a method of estimating the reproducibility and least significant change (LSC) values for RAIU measurements, and the implications of the values observed are discussed, with emphasis on application to quality assurance initiatives. Methods: We prospectively studied 36 consecutive patients referred for RAIU measurements. Twenty-four hours after oral administration of 370 kBq of 131I-NaI in capsule form, RAIU measurements were obtained in duplicate using a thyroid probe uptake system. Assessment of reproducibility was performed using root-mean-square standard deviation. Results: Average difference between duplicated RAIU measurements in our study cohort was -0.1 ± 1.6% and ranged from -4.8% to 3.1%. Reproducibility of probe-based RAIU measurement was calculated to be 1.1% and 95% LSC was 3.2%. Conclusion: In our clinic, probe-based RAIU is a reproducible and relatively precise measurement. Using the method we have outlined, each institution can perform reproducibility assessment and compute the LSC of RAIU measurements based on its own staff, iodine isotope, equipment, protocols, and patient population. These values are useful in the assessment of serial change in RAIU, and as more experience is accumulated, can serve as benchmarks to be used in quality assurance initiatives.

KW - Hyperthyroidism

KW - Radioiodine therapy

KW - Radioiodine thyroid uptake

KW - Reproducibility

UR - http://www.scopus.com/inward/record.url?scp=85034791749&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034791749&partnerID=8YFLogxK

U2 - 10.1002/acm2.12217

DO - 10.1002/acm2.12217

M3 - Article

C2 - 29165912

AN - SCOPUS:85034791749

VL - 19

SP - 239

EP - 242

JO - Journal of Applied Clinical Medical Physics

JF - Journal of Applied Clinical Medical Physics

SN - 1526-9914

IS - 1

ER -